AR042674A1 - [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast - Google Patents

[4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast

Info

Publication number
AR042674A1
AR042674A1 ARP030104855A ARP030104855A AR042674A1 AR 042674 A1 AR042674 A1 AR 042674A1 AR P030104855 A ARP030104855 A AR P030104855A AR P030104855 A ARP030104855 A AR P030104855A AR 042674 A1 AR042674 A1 AR 042674A1
Authority
AR
Argentina
Prior art keywords
inhibitor
fluorophenyletinyl
aminometilphenil
triptase
metanone
Prior art date
Application number
ARP030104855A
Other languages
English (en)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of AR042674A1 publication Critical patent/AR042674A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se extiende al compuesto de fórmula (1), o un profármaco, sal farmacéuticamente aceptable, o solvato de dicho compuesto; a una composición farmacéutica que comprende una cantidad farmacéuticamente efectiva del compuesto de fórmula (1), y un vehículo farmacéuticamente aceptable; al uso de un compuesto de fórmula (1) como un inhibidor de triptasa, que comprende introducir el compuesto en una composición que comprende triptasa.
ARP030104855A 2002-12-26 2003-12-29 [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast AR042674A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43653402P 2002-12-26 2002-12-26

Publications (1)

Publication Number Publication Date
AR042674A1 true AR042674A1 (es) 2005-06-29

Family

ID=23732791

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104855A AR042674A1 (es) 2002-12-26 2003-12-29 [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast

Country Status (9)

Country Link
US (1) US20040192734A1 (es)
AR (1) AR042674A1 (es)
AU (1) AU2003301137A1 (es)
GB (1) GB0308613D0 (es)
PA (1) PA8593701A1 (es)
PE (1) PE20040931A1 (es)
TW (1) TW200508227A (es)
UY (1) UY28152A1 (es)
WO (1) WO2004060884A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1571150A1 (en) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Process for the preparation of tryptase inhibitors
WO2006044133A1 (en) * 2004-09-24 2006-04-27 Axys Pharmaceuticals, Inc. Active ketone inhibitors of tryptase
US8158792B2 (en) 2007-11-21 2012-04-17 Janssen Pharmaceutica N.V. Spiropiperidines for use as tryptase inhibitors
CN111568894B (zh) * 2020-05-18 2021-07-27 中国医学科学院肿瘤医院 2-(乙基氨甲基)-5-(苯基)呋喃在制备用于抑制tlr7/8的药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1230431C (zh) * 2000-05-22 2005-12-07 阿温蒂斯药物公司 用作类胰蛋白酶抑制剂的芳基甲胺衍生物

Also Published As

Publication number Publication date
UY28152A1 (es) 2004-07-30
WO2004060884A1 (en) 2004-07-22
TW200508227A (en) 2005-03-01
US20040192734A1 (en) 2004-09-30
GB0308613D0 (en) 2003-05-21
AU2003301137A1 (en) 2004-07-29
PE20040931A1 (es) 2004-12-24
PA8593701A1 (es) 2005-05-24

Similar Documents

Publication Publication Date Title
AR049274A1 (es) Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
UY29825A1 (es) Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones
PA8591701A1 (es) Derivados de pirrolopirimidina
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
CR7548A (es) Derivados de triazole como antagonistas del receptor de tachykinin
ECSP099436A (es) Acilaminopirazoles como inhibidores de fgfr
SE0202463D0 (sv) Novel compounds
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
AR039335A1 (es) Tableta de carga de droga alta
AR061134A1 (es) Derivados de tioxantina
DOP2009000124A (es) Derivados de benzamida como receptores agonista ep4
AR052853A1 (es) Composiciones orales que contienen compuestos antibacterianos de bifenol
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
PA8495101A1 (es) Derivados de 13-metileritromicina
PA8561501A1 (es) Lactamas como antagonistas de taquiquininas
UY27980A1 (es) Indoles 2,7-sustituidos
WO2005097100A3 (en) Antibacterial agents
AR052488A1 (es) Derivados de 2-quinolonas como inhibidores de fosfodiesterasas
PA8579301A1 (es) Derivados de tiazol
ATE408610T1 (de) Alkyl-und piperidin-substitutierte benzimidazol- derivate

Legal Events

Date Code Title Description
FB Suspension of granting procedure